최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of the American College of Cardiology, v.53 no.21, 2009년, pp.1925 - 1932
Lavie, C.J. , Milani, R.V. , Ventura, H.O.
Obesity has reached global epidemic proportions in both adults and children and is associated with numerous comorbidities, including hypertension (HTN), type II diabetes mellitus, dyslipidemia, obstructive sleep apnea and sleep-disordered breathing, certain cancers, and major cardiovascular (CV) dis...
Circulation Poirier 113 898 2006 10.1161/CIRCULATIONAHA.106.171016
Circulation Klein 110 2952 2004 10.1161/01.CIR.0000145546.97738.1E
J Am Coll Cardiol Litwin 52 616 2008 10.1016/j.jacc.2008.05.017 Which measures of obesity best predict cardiovascular risk?
N Engl J Med Pischon 359 2105 2008 10.1056/NEJMoa0801891 General and abdominal adiposity and risk of death in Europe
JAMA Flegal 288 1723 2002 10.1001/jama.288.14.1723 Prevalence and trends in obesity among US adults, 1999-2000
J Am Coll Cardiol Lavie 42 677 2003 10.1016/S0735-1097(03)00784-8 Obesity and cardiovascular disease: the Hippocrates paradox?
JAMA Manson 289 229 2003 10.1001/jama.289.2.229 Obesity in the United States: a fresh look at its high toll
Public Health Sturm 115 229 2001 10.1016/S0033-3506(01)00449-8 Does obesity contribute as much to morbidity as poverty or smoking?
J Am Coll Cardiol Ford 50 2128 2007 10.1016/j.jacc.2007.05.056 Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates
J Am Coll Cardiol Martin 52 1201 2008 10.1016/j.jacc.2008.05.060 Leptin resistance
Nat Clin Pract Cardiovasc Med Lavie 5 428 2008 10.1038/ncpcardio1257 Untangling the heavy cardiovascular burden of obesity
Obesity Enriori 14 Suppl 5 254S 2006 10.1038/oby.2006.319 Leptin resistance and obesity
Nat Clin Pract Cardiovasc Med Romero-Corral 5 418 2008 10.1038/ncpcardio1218 Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population
Am J Med Sci Alpert 321 225 2001 10.1097/00000441-200104000-00003 Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome
Circulation Messerli 66 55 1982 10.1161/01.CIR.66.1.55 Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output
Arch Intern Med Messerli 147 1725 1987 10.1001/archinte.1987.00370100039008 Overweight and sudden death: increased ventricular ectopy in cardiomyopathy of obesity
N Engl J Med Messerli 314 378 1986 10.1056/NEJM198602063140608 Cardiomyopathy of obesity: a not-so-Victorian disease
Am J Cardiol Lavie 100 1460 2007 10.1016/j.amjcard.2007.06.040 Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction
Chest Lavie 92 1042 1987 10.1378/chest.92.6.1042 Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesity
JAMA Wang 292 2471 2004 10.1001/jama.292.20.2471 Obesity and the risk of new-onset atrial fibrillation
Am J Cardiol Chakko 68 95 1991 10.1016/0002-9149(91)90718-Z Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity
Am J Cardiol Garavaglia 62 594 1988 10.1016/0002-9149(88)90662-5 Myocardial contractility and left ventricular function in obese patients with essential hypertension
Am J Cardiol Alpert 80 736 1997 10.1016/S0002-9149(97)00505-5 Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss
Am J Med Uretsky 120 863 2007 10.1016/j.amjmed.2007.05.011 Obesity paradox in patients with hypertension and coronary artery disease
Arch Intern Med Wassertheil-Smoller 160 494 2000 10.1001/archinte.160.4.494 Relation of low body mass to death and stroke in the systolic hypertension in the elderly program
Hypertension Stamler 17 553 1991 10.1161/01.HYP.17.4.553 Why do lean hypertensive patients have higher mortality rates than other hypertensive patients?
Am J Med Tuomilehto 90 34S 1991 10.1016/0002-9343(91)90434-Y Body mass index and prognosis in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly
Am J Med Lavie 120 825 2007 10.1016/j.amjmed.2007.06.023 Obesity, heart disease, and favorable prognosis-truth or paradox?
N Engl J Med Kenchaiah 347 305 2002 10.1056/NEJMoa020245 Obesity and the risk of heart failure
J Am Coll Cardiol Horwich 38 789 2001 10.1016/S0735-1097(01)01448-6 The relationship between obesity and mortality in patients with heart failure
Am J Cardiol Lavie 91 891 2003 10.1016/S0002-9149(03)00031-6 Body composition and prognosis in chronic systolic heart failure: the obesity paradox
Circulation Lavie 116 II360 2007 Does body composition impact survival in patients with advanced heart failure (abstr)
Am Heart J Oreopoulos 156 13 2008 10.1016/j.ahj.2008.02.014 Body mass index and mortality in heart failure: a meta-analysis
Am Heart J Fonarow 153 74 2007 10.1016/j.ahj.2006.09.007 An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the acute decompensated heart failure national registry
Eur Heart J Lavie 26 5 2005 10.1093/eurheartj/ehi055 Obesity and heart failure prognosis: paradox or reverse epidemiology
J Am Coll Cardiol Kalantar-Zadeh 43 1439 2004 10.1016/j.jacc.2003.11.039 Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure
Lancet Anker 361 1077 2003 10.1016/S0140-6736(03)12892-9 Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting enzyme inhibitors: an observational study
Am J Physiol Mohamed-Ali 277 E971 1999 Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo
J Am Coll Cardiol Mehra 43 1590 2004 10.1016/j.jacc.2003.10.066 Obesity and suppressed B-type natriuretic peptide levels in heart failure
Lancet Rauchhaus 356 930 2000 10.1016/S0140-6736(00)02690-8 The endotoxin-lipoprotein hypothesis
Circulation Hubert 67 968 1983 10.1161/01.CIR.67.5.968 Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study
J Cardiopulm Rehabil Lavie 25 59 2005 10.1097/00008483-200503000-00001 Cardiac rehabilitation and exercise training programs in metabolic syndrome and diabetes
J Am Coll Cardiol Gelber 52 605 2008 10.1016/j.jacc.2008.03.066 Measures of obesity and cardiovascular risk among men and women
Circulation Zhang 117 1658 2008 10.1161/CIRCULATIONAHA.107.739714 Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women
J Am Coll Cardiol Madala 52 979 2008 10.1016/j.jacc.2008.04.067 Obesity and age of first non-ST-segment elevation myocardial infarction
Lancet Romero-Corral 368 666 2006 10.1016/S0140-6736(06)69251-9 Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies
Am J Med Lavie 2009 10.1016/j.amjmed.2009.06.006 The obesity paradox, weight loss, and coronary disease
Am J Med McAuley 120 518 2007 10.1016/j.amjmed.2006.07.032 Body mass, fitness and survival in veteran patients: another obesity paradox?
Chest Galal 134 925 2009 10.1378/chest.08-0418 The obesity paradox in patients with peripheral arterial disease: the influence of chronic obstructive pulmonary disease
Chest Lavie 134 896 2009 10.1378/chest.08-1673 The “obesity paradox”-is smoking/lung disease the explanation?
Am Heart J Wanahita 155 310 2008 10.1016/j.ahj.2007.10.004 Atrial fibrillation and obesity-results of a meta-analysis
Arch Intern Med Kurth 162 2557 2002 10.1001/archinte.162.22.2557 Body mass index and the risk of stroke in men
Chadwick 154 1950 Medical Works of Hippocrates
Am Heart J Kannel 115 869 1988 10.1016/0002-8703(88)90891-5 Cardiac failure and sudden death in the Framingham Study
Am J Cardiol el-Gamal 75 956 1995 10.1016/S0002-9149(99)80700-0 Effects of obesity on QT, RR, and QTc intervals
Proc Soc Exp Biol Med Mshui 220 133 1999 10.3181/00379727-220-44355 QT interval and QT dispersion before and after diet therapy in patients with simple obesity
Acta Med Scand Rasmussen 217 271 1985 10.1111/j.0954-6820.1985.tb02694.x The relationship between QTc changes and nutrition during weight loss after gastroplasty
Obes Res Lalani 8 20 2000 10.1038/oby.2000.4 Abnormal signal-averaged electrocardiogram (SAECG) in obesity
N Engl J Med Trollo 334 99 1996 10.1056/NEJM199601113340207 Obstructive sleep apnea
Circulation Shamsuzzaman 28 2462 2002 10.1161/01.CIR.0000018948.95175.03 Elevated C-reactive protein in patients with obstructive sleep apnea
Chest Partinen 94 1200 1988 10.1378/chest.94.6.1200 Long-term outcome for obstructive sleep apnea syndrome patients
Ann Surg Sugerman 234 41 2001 10.1097/00000658-200107000-00007 Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease
Arch Intern Med Tsai 162 1182 2002 10.1001/archinte.162.10.1182 Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology
JAMA Goldhaber 277 642 1997 10.1001/jama.1997.03540320044033 A prospective study of risk factors for pulmonary embolism in women
J Am Coll Cardiol Fonarow 39 1563 2002 10.1016/S0735-1097(02)01807-7 Obesity, weight reduction and survival in heart failure: reply
Int J Obes Relat Metab Disord Allison 23 603 1999 10.1038/sj.ijo.0800875 Weight loss increases and fat loss decreases all-cause mortality rates: results from two independent cohort studies
Eur Cardiovasc Prev Rehabil Sierra-Johnson 15 336 2008 10.1097/HJR.0b013e3282f48348 Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index
Obes Rev Sorensen 4 3 2003 10.1046/j.1467-789X.2003.00090.x Weight loss causes increased mortality: pros
N Engl J Med Connolly 337 581 1997 10.1056/NEJM199708283370901 Valvular heart disease associated with fenfluramine-phentermine
N Engl J Med Albenhaim 335 609 1996 10.1056/NEJM199608293350901 Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Am Heart J Zannad 144 508 2002 10.1067/mhj.2002.124403 Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction
N Engl J Med Knowler 346 393 2002 10.1056/NEJMoa012512 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
N Engl J Med Tuomilehto 344 1343 2001 10.1056/NEJM200105033441801 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
Am J Cardiol Milani 92 50 2003 10.1016/S0002-9149(03)00464-8 Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation
Am J Cardiol Lavie 79 397 1997 10.1016/S0002-9149(97)89239-9 Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients
J Cardiometab Syndr Lavie 3 136 2008 10.1111/j.1559-4572.2008.00002.x Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients
Am J Epidemiol Eilat-Adar 161 352 2005 10.1093/aje/kwi045 Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor
Am J Cardiol MacMahon 63 202 1989 10.1016/0002-9149(89)90286-5 Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the multiple risk factor intervention trial
J Am Coll Surg Flum 199 543 2004 10.1016/j.jamcollsurg.2004.06.014 Impact of gastric bypass operation on survival: a population-based analysis
N Engl J Med Adams 357 753 2007 10.1056/NEJMoa066603 Long-term mortality after gastric bypass surgery
N Engl J Med Sjostrom 357 741 2007 10.1056/NEJMoa066254 Effects of bariatric surgery on mortality in Swedish obese subjects
Ann Surg Christou 240 416 2004 10.1097/01.sla.0000137343.63376.19 Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients
Mayo Clin Proc Batsis 83 897 2008 10.1016/S0025-6196(11)60766-0 Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study
Am J Cardiol Batsis 102 930 2008 10.1016/j.amjcard.2008.05.040 Cardiovascular risk after bariatric surgery for obesity
Hypertension Sjostrom 36 20 2000 10.1161/01.HYP.36.1.20 Differentiated long-term effects of intentional weight loss on diabetes and hypertension
Clin Cardiol Ramani 31 516 2008 10.1002/clc.20315 Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.